INSTITUT DE RECERCA BIOMEDICA DE LLEIDA FUNDACIO DOCTOR PIFARRE

Their core work

IRBLleida is a biomedical research foundation based in Lleida, Spain, focused on clinical and translational research in chronic diseases — particularly kidney disease, cardiovascular conditions, and connected health solutions for complex patients. They contribute clinical expertise and patient data to EU consortia working on personalised medicine, disease registries, and decision support systems for chronic care management. More recently, they have expanded into applied research on animal welfare science and smart sensor technologies for health monitoring.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2017), IRBLleida focused squarely on biomedical research — chronic kidney disease, personalised medicine, patient empowerment, and connected care for complex chronic patients. From 2019 onward, their portfolio diversified significantly into animal welfare biology, smart sensor platforms (radar, lidar, edge computing), and microfabricated medical devices. This shift suggests the institute is broadening from purely clinical research toward technology-enabled health applications and interdisciplinary life sciences.

IRBLleida is moving from clinical-only research toward health technology integration — particularly smart sensors and medical devices — making them an increasingly versatile partner for digital health consortia.

How they like to work

IRBLleida operates exclusively as a consortium participant or third party — they have never coordinated an H2020 project. With 162 unique partners across 20 countries in just 6 projects, they join large, well-connected consortia rather than leading small focused teams. This profile suggests a reliable specialist contributor that brings clinical or domain expertise to ambitious multi-partner projects without seeking the administrative burden of coordination.

Despite only 6 projects, IRBLleida has built an extensive network of 162 unique partners across 20 countries, reflecting their participation in large-scale EU consortia. Their reach is decidedly pan-European with no visible concentration in a single geographic cluster.

What sets them apart

IRBLleida sits at the intersection of clinical biomedical research and emerging digital health — a combination that is relatively rare among Spanish research centres of this size. Their hands-on experience with chronic disease registries, patient monitoring systems, and now smart sensor technologies makes them a natural bridge between clinical end-users and technology developers in health-focused consortia. For consortium builders, they offer a hospital-affiliated research environment that can validate digital health tools in real clinical settings.

Highlights from their portfolio

• CONNECARE
  Their largest H2020 project (EUR 469K) and most aligned with their core mission — personalised connected care with decision support for complex chronic patients.
• IMPROVE-PD
  An MSCA training network on peritoneal dialysis where they joined as third party, indicating recognised niche expertise in kidney disease research.
• NextPerception
  Marks a clear strategic expansion into smart sensors (radar, lidar, edge computing) and explainable AI for human monitoring — a new direction for a biomedical institute.